arrow
U

Ulrike Protzer

Technical University of Munich and Helmholtz Munich
H指数:76
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Decoupling reactogenicity from efficacy enables safer mRNA vaccines, AAV gene delivery, and in vivo base editing

将免疫原性与有效性解耦可实现更安全的mRNA疫苗、AAV基因递送和体内碱基编辑

2026-09-280
OAAI
Long-Term Humoral Immune Dynamics in Healthcare Workers with Hybrid and Vaccine-Induced Immunity: The VaCoMRI Study

具有混合免疫和疫苗诱导免疫的医疗保健工作者长期体液免疫动力学:VaCoMRI研究

2026-09-200
OA
Cuproptosis in iron overload hepatocytes

铜死亡在铁过载肝细胞中

2026-09-190
OAAI
Nasal Epithelial Immune Signatures Are Associated With Age-Dependent Asthma Trajectories in Early Life

鼻上皮免疫特征与生命早期年龄依赖性哮喘轨迹相关

2026-09-070
OAAI
Helminth infection modulates the immunogenicity of COVID-19 vaccines in mice without compromising protective efficacy

蠕虫感染在不影响保护效果的前提下调节小鼠中COVID-19疫苗的免疫原性

2026-05-280
OAAI
Correction: Maurer et al. Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis. J. Fungi 2022, 8, 1265

更正:Maurer等人. COVID-19相关肺曲霉菌病危重症患者肠道微生物紊乱。真菌学杂志,2022年,8卷,1265页。

2026-04-040
OAAI
The composition of MDSC-subpopulations PMN-like; M-like; and e-like MDSC is associated with the severity of infectious mononucleosis in pediatric patients

MDSC亚群PMN-like、M-like和e-like MDSC的组成与儿科患者传染性单核细胞增多症的严重程度相关

2026-03-310
OAAI
Therapeutic hepatitis B vaccine employing DNA prime – MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response

采用DNA初免–MVA加强方案的乙肝治疗性疫苗需要用重组HBsAg进行额外初免以诱导足够的抗体应答。

2026-03-120
OAAI
Early mucosal type 1 immunity in pre-school wheezers as protective factor for development of asthma at school-age

学龄前哮喘的早期1型粘膜免疫可作为学龄哮喘发展的保护因素

2025-11-010
PRE
Prediction of COVID-19 disease progression by multiparametric analysis of circulating extracellular vesicles with flow cytometry

通过流式细胞术对循环外泌体进行多参数分析预测COVID-19疾病进展

2025-09-010
PRE
Multi-proteomic profiling of the varicella-zoster virus–host interface reveals host susceptibilities to severe infection

水痘-带状疱疹病毒-宿主界面的多蛋白质组学分析揭示了宿主对严重感染的易感性

2025-07-300
OA
MVA-HBVac—A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination

MVA-HBVac——一种新型疫苗载体,可通过治疗性疫苗接种实现针对乙型肝炎病毒的全基因型靶向。

2025-07-230
OAAI